Geode Capital Management’s Lexaria Bioscience LEXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$229K Buy
19,610
+4,962
+34% +$54K ﹤0.01% 3866
2025
Q4
$136K Buy
14,648
+2,996
+26% +$42.5K ﹤0.01% 4023
2025
Q3
$167K Hold
11,652
﹤0.01% 3984
2025
Q2
$152K Buy
11,652
+155
+1% +$2.67K ﹤0.01% 3955
2025
Q1
$295K Buy
11,497
+385
+3% +$9.8K ﹤0.01% 3725
2024
Q4
$350K Buy
11,112
+1,086
+11% +$40.1K ﹤0.01% 3710
2024
Q3
$459K Buy
10,026
+2,374
+31% +$113K ﹤0.01% 3611
2024
Q2
$319K Buy
7,652
+1,029
+16% +$46.3K ﹤0.01% 3739
2024
Q1
$361K Buy
6,623
+3,050
+85% +$117K ﹤0.01% 3727
2023
Q4
$67K Buy
3,573
+412
+13% +$7.96K ﹤0.01% 4282
2023
Q3
$47K Sell
3,161
-95
-3% -$1.3K ﹤0.01% 4433
2023
Q2
$35.3K Hold
3,256
﹤0.01% 4577
2023
Q1
$133K Hold
3,256
﹤0.01% 4233
2022
Q4
$119K Sell
3,256
-11
-0.3% -$395 ﹤0.01% 4330
2022
Q3
$120K Sell
3,267
-61
-2% -$2.61K ﹤0.01% 4487
2022
Q2
$148K Buy
3,328
+61
+2% +$2.45K ﹤0.01% 4419
2022
Q1
$161K Hold
3,267
﹤0.01% 4476
2021
Q4
$198K Hold
3,267
﹤0.01% 4472
2021
Q3
$306K Sell
3,267
-92
-3% -$8.82K ﹤0.01% 4260
2021
Q2
$352K Buy
+3,359
New +$300K ﹤0.01% 4095

Other funds holding LEXX

Geode Capital Management's LEXX Position: Q1 2026 in Review

Geode Capital Management increased its Lexaria Bioscience (LEXX) stake by 34% in Q1 2026, buying an estimated $54K and bringing the position to 19,610 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #3866.

Geode Capital Management first reported a position in LEXX in Q2 2021 and has held it in 20 quarters since. The position peaked at $459K in Q3 2024. 25 funds tracked by Wall St. Rank hold LEXX as of Q1 2026.

  • Geode Capital Management held 19,610 shares of Lexaria Bioscience worth $229K as of Q1 2026.
  • Geode Capital Management bought 4,962 Lexaria Bioscience shares in Q1 2026, an estimated $54K.
  • Lexaria Bioscience made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3866 holding.
  • Geode Capital Management first reported a position in Lexaria Bioscience in Q2 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Lexaria Bioscience position peaked at $459K in Q3 2024.
  • 25 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.